Seeing Is Believing
Ambrx Biopharma American Depositary Shares's activity chart (see below) currently has 21 price targets and 19 ratings on display.
Analysts average stock forecasts to be materialized ratio is 69.58% with an average time for these price targets to be met of 80.08 days.
Most recent stock forecast was given by from BAIRD on 16-Jan-2024. First documented stock forecast 13-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2022
$22
$-6 (-21.43%)
$22
Hold Since 01-Mar-2022
$9
$-19 (-67.86%)
$10
Buy Since 31-Jul-2023
$32
$4 (14.29%)
$33
What is AMAM (Ambrx Biopharma American Depositary Shares) average time for price targets to be met?
Which analyst has the current highest performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?
Which analyst has the most public recommendations on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most bullish on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most reserved on AMAM (Ambrx Biopharma American Depositary Shares)?